JSC "Farmak" (primary and secondary packaging, labeling, batch release of bulk products manufactured by Oman Pharmaceuticals Products Co. LLC, Oman)

Ukraine

All drugs from this manufacturer

  • AYGLIMET

    The drug is indicated for the treatment of patients with type 2 diabetes mellitus (as an adjunct to diet and exercise) in cases where glucose levels are not controlled by metformin alone, or when switching from separate preparations of vildagliptin and metformin.

    Dosage form: tablets, film-coated

    Active substance Dosage
    villogliptin 50 mg
    metformin 850 mg

    ATC: A10BD08